Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
1.
Curr Microbiol ; 63(2): 131-7, 2011 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-21626145

RESUMO

The etiopathogenesis of Crohn's disease (CD) is still controversial: several genetic, immunologic, and environmental factors, including some bacteria, have been implicated. This study has been devised to assess the involvement of Escherichia coli in CD. Seven E. coli strains were isolated from 14 biopsies obtained from ileocolic ulcers of patients affected by inflammatory bowel disease (IBD), including six with ulcerative colitis and eight with CD. Five strains, exclusively isolated from CD patients, were found inside mucosal cells. Different PCR techniques (for chuA, yjaA, TspE4.C2, escV, and bfpB genes) were performed and PFGE was carried out to characterize these bacteria in comparison with other E. coli strains isolated from non-IBD specimens. The correlation of these characters with bacterial invasiveness on intestinal (Caco-2) and phagocytic (U937) cells was assessed. Overall our pilot data suggest that five among eight strains isolated from CD patients belonged to the adherent-invasive E. coli (AIEC) group, and were invasive on Caco-2 cells and resistant to phagocytosis. These findings suggest that these bacteria could be considered target organisms whose elimination could reduce the intestinal inflammatory process and CD progression.


Assuntos
Doença de Crohn/microbiologia , Escherichia coli/isolamento & purificação , Adolescente , Adulto , Aderência Bacteriana , Biópsia , Linhagem Celular , Análise por Conglomerados , Eletroforese em Gel de Campo Pulsado , Células Epiteliais/microbiologia , Escherichia coli/classificação , Escherichia coli/genética , Proteínas de Escherichia coli/genética , Feminino , Genótipo , Humanos , Mucosa Intestinal/microbiologia , Masculino , Pessoa de Meia-Idade , Tipagem Molecular , Monócitos/microbiologia , Adulto Jovem
2.
Dig Liver Dis ; 42 Suppl 6: S381-406, 2010 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-21078490

RESUMO

This paper gives practical guidelines for diagnosis and treatment of chronic pancreatitis. Statements have been elaborated by working teams of experts, by searching for and analysing the literature, and submitted to a consensus process by using a Delphi modified procedure. The statements report recommendations on clinical and nutritional approach, assessment of pancreatic function, treatment of exocrine pancreatic failure and of secondary diabetes, treatment of pain and prevention of painful relapses. Moreover, the role of endoscopy in approaching pancreatic pain, pancreatic stones, duct narrowing and dilation, and complications was considered. Recommendations for most appropriate use of various imaging techniques and of ultrasound endoscopy are reported. Finally, a group of recommendations are addressed to the surgical treatment, with definition of right indications, timing, most appropriate procedures and techniques in different clinical conditions and targets, and clinical and functional outcomes following surgery.


Assuntos
Pancreatite Crônica/diagnóstico , Pancreatite Crônica/terapia , Humanos , Itália
4.
JOP ; 8(1 Suppl): 114-7, 2007 Jan 09.
Artigo em Inglês | MEDLINE | ID: mdl-17228143

RESUMO

The sequelae of pancreas surgery are determined by the type of procedure, the extent of the parenchymal resection and the underlying disorder. In ductal carcinoma, the outcome is heavily influenced by the disease itself. Mortality rates are lower in centers which perform the most operations. In chronic pancreatitis, surgical management is essentially therapeutic for complications and palliative for the disease whose progress is closely correlated with the sequelae. Elective surgery does not appear to increase the risk of diabetes whereas distal pancreatectomy is an independent risk factor. Parenchymal resection aggravates nutritional deficiencies, such as low selenium, linoleic acid, LDL and apolipoprotein B levels, and thus increases the risk of atherogenesis. Abstinence from alcohol is an indispensable step towards the disappearance of postoperative pain.


Assuntos
Pancreatectomia/efeitos adversos , Complicações Pós-Operatórias , Humanos , Pancreatopatias/cirurgia
5.
J Gastroenterol Hepatol ; 21(12): 1801-6, 2006 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-17074017

RESUMO

BACKGROUND: Eleven liver biopsies from six male patients who received a liver transplant (LT) from female donors were examined in order to determine whether male host-derived hepatic cells were present in female grafts that exhibited minimal or important inflammatory damage. METHODS: Immunohistochemistry for epithelial cell type differentiation (anticytokeratin monoclonal antibody) and fluorescence in situ hybridization for XY chromosomes identification were performed on each slide. RESULTS: Host-derived hepatic cells were found in all except one transplant, with a frequency ranging from 2.3 to 25 per thousand of the total hepatocytes in the biopsy specimen. They were usually found as isolated cells scattered throughout the hepatic lobule; in one patient they were grouped into little clusters. Host-derived hepatic cells persisted throughout the histological follow up (up to 535 days after LT). Polyploidy for XY chromosome was observed. CONCLUSION: Hepatocytes derived from extra-hepatic stem cells are frequently found in small numbers in human liver grafts and persist over time.


Assuntos
Diferenciação Celular/genética , Quimerismo , Células Epiteliais/patologia , Transplante de Fígado/patologia , Idoso , Biópsia , Cromossomos Humanos X/genética , Cromossomos Humanos Y/genética , Feminino , Seguimentos , Hepatócitos/patologia , Humanos , Imuno-Histoquímica , Hibridização in Situ Fluorescente , Masculino , Pessoa de Meia-Idade , Poliploidia , Estudos Retrospectivos
6.
Free Radic Biol Med ; 41(3): 443-54, 2006 Aug 01.
Artigo em Inglês | MEDLINE | ID: mdl-16843825

RESUMO

Cells of colonic mucosa are sensitive to the Smad-mediated growth-inhibitory effect of transforming growth factor-beta1 (TGF-beta1). Another important cell growth inhibitor is the polyunsaturated lipid peroxidation end product, 4-hydroxynonenal (HNE), which triggers apoptosis through c-Jun N-terminal kinase (JNK) activation. Interestingly, a close association between TGF-beta1 and HNE was found in the progression of human colon cancer, with concentration of both molecules inversely related to the malignancy. We investigated the cross talk between Smads and JNK signal transduction pathways in inducing apoptosis. To this purpose TGF-beta1 and HNE were added singly or in combination to CaCo-2 human colon adenocarcinoma cells. The cotreatment induced a marked enhancement of apoptosis and of JNK and Smad4 activities much more than either individual molecule. Cell preincubation with the JNK inhibitor SP600125 significantly prevented JNK and Smad4 enhancement and, subsequently, the cooperative proapoptotic effect was abolished. The primary role of JNK activity in TGF-beta1/HNE cooperative signaling was fully confirmed in a second set of experiments by using JNKi I, a more selective kinase inhibitor. Hence, in tumor cells becoming resistant to TGF-beta1-mediated growth inhibition, increased induction of the remaining TGF-beta1 pathways by interaction with other antiproliferative molecules, such as HNE, could help in inhibiting tumor growth.


Assuntos
Aldeídos/metabolismo , Apoptose , Colo/citologia , Colo/enzimologia , Mucosa Intestinal/enzimologia , Proteínas Quinases JNK Ativadas por Mitógeno/metabolismo , Fator de Crescimento Transformador beta1/metabolismo , Adulto , Idoso , Aldeídos/farmacologia , Antracenos/farmacologia , Apoptose/efeitos dos fármacos , Células CACO-2 , Caspase 3/metabolismo , Colo/efeitos dos fármacos , Ativação Enzimática/efeitos dos fármacos , Feminino , Humanos , Mucosa Intestinal/citologia , Mucosa Intestinal/efeitos dos fármacos , Proteínas Quinases JNK Ativadas por Mitógeno/antagonistas & inibidores , Masculino , Pessoa de Meia-Idade , Inibidores de Proteínas Quinases/farmacologia , Transdução de Sinais/efeitos dos fármacos , Proteína Smad4/metabolismo , Fator de Crescimento Transformador beta1/farmacologia , Regulação para Cima/efeitos dos fármacos
9.
J Clin Endocrinol Metab ; 90(1): 84-90, 2005 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-15507515

RESUMO

Acromegaly is an infrequent disease attributable to endogenous excess of GH and IGF-I. Human studies have associated the GH-IGF-I axis with the development of colorectal cancer; however, the question of whether colorectal cancer is a problem in acromegaly is currently unresolved. We performed a cross-sectional study to assess the risk of colonic neoplasia in patients with acromegaly. Colonoscopic screening was performed in 235 patients with acromegaly at five tertiary care hospitals in Italy between January 1, 1996, and December 31, 2001. A repeat colonoscopy was performed in 121 patients after a mean interval of 32.1 months. Colonoscopic findings in patients with acromegaly were compared with those of 233 patients with nonspecific abdominal complaints who were referred for endoscopy during the study period. A total of 65 patients (27.7%) and 36 controls (15.5%) had colonic neoplasia. In 55 patients (23.4%) and 34 control subjects (14.6%), the most important findings were adenomas (odds ratio, 1.7; range, 1.1-2.5), whereas 10 patients (4.3%) and two control subjects (0.9%) had carcinoma (odds ratio, 4.9; range, 1.1-22.4). The risk of colonic neoplasia was higher for younger patients with acromegaly compared with age-matched controls. Patients with acromegaly with or without colonic neoplasia did not differ significantly for IGF-I levels or duration of disease. A neoplastic recurrence was found in 16.5% of patients who underwent follow-up; 90% of them had had a neoplasm removed at the first colonoscopy. Acromegaly carries with it a moderate, but definitive, increase in the risk of colonic neoplasia that occurs at a younger age than in the general population. Patients who are found to harbor a colonic neoplasia are at risk for recurrence.


Assuntos
Acromegalia/complicações , Colonoscopia , Adulto , Idoso , Idoso de 80 Anos ou mais , Neoplasias do Colo/etiologia , Estudos Transversais , Feminino , Seguimentos , Humanos , Fator de Crescimento Insulin-Like I/análise , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos
11.
Eur J Hum Genet ; 12(3): 206-12, 2004 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-14747834

RESUMO

CARD15 on chromosome 16 is the only IBD susceptibility gene identified among several mapped loci. Its recurrent variants R702W, G908R and L1007fs have shown significant association with Crohn's disease (CD), but not with ulcerative colitis (UC), in different Caucasian populations. We analysed these three variants in 184 CD and 92 UC Italian patients and in 177 healthy controls. L1007fs and G908R were independently associated with CD, while R702W showed a nonsignificant increase. After combining the three variants together, 32.6% of CD patients were positive vs 18.6% of the controls. The association was stronger for homozygotes and compound heterozygotes, OR 13.9 (1.8-108), and weaker but still significant for simple heterozygotes, OR 1.7 (1.0-2.9). An excess of homozygotes/compound heterozygotes also resulted from the comparison with Hardy-Weinberg expectations. Phenotype-genotype correlations were analysed first by univariate logistic regression and then by multivariate analysis, the effect of CARD15 positivity being adjusted according to the status of smoking, familiarity and sex, so as to focus on the predictivity of genetic and environmental risk factors on the clinical phenotype. Significant risk estimates of the CARD15 genotype were obtained for stricturing vs inflammatory behaviour, OR 2.76 (1.2-6.3), and for penetrating behaviour, 2.59 (1.0-6.6), and marginally significant for ileal vs colic location, OR 3.0 (0.9-9.8). Our findings indicate that the association of the CARD15 genotype with behaviour and location of disease holds also for the Italian population.


Assuntos
Proteínas de Transporte/genética , Colite Ulcerativa/genética , Doença de Crohn/genética , Variação Genética/genética , Peptídeos e Proteínas de Sinalização Intracelular , Análise Mutacional de DNA , Mutação da Fase de Leitura/genética , Frequência do Gene , Heterozigoto , Homozigoto , Humanos , Itália , Desequilíbrio de Ligação , Mutação de Sentido Incorreto/genética , Proteína Adaptadora de Sinalização NOD2 , Fenótipo
12.
Dig Dis Sci ; 47(11): 2416-21, 2002 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-12452372

RESUMO

Mutations in the cationic trypsinogen, cystic fibrosis transmembrane conductance regulator (CFTR) and pancreatic secretory trypsinogen inhibitor (PSTI) genes have recently been associated with chronic pancreatitis. This paper investigates the frequency of CFTR and PSTI gene mutation in patients with idiopathic and alcoholic chronic pancreatitis, the clinical course of patients with these two kinds of disease, and examines the clinical differences between carriers and noncarriers of mutation. In idiopathic pancreatitis a significant increase was found in mutation frequency both in the CFTR gene (13%) and N34S mutation in the PSTI gene (3.9%), as well as an increase in familial disposition to pancreatic disorders. In alcohol-induced pancreatitis an increase in calcification, exocrine insufficiency, and diabetes mellitus was observed. In conclusions, mutations in the genes investigated are involved in causing idiopathic pancreatitis. Such mutations have no connection either with the age at onset or the clinical course of the disease.


Assuntos
Regulador de Condutância Transmembrana em Fibrose Cística/genética , Mutação em Linhagem Germinativa , Substâncias de Crescimento/genética , Peptídeos e Proteínas de Sinalização Intercelular/genética , Pancreatite/genética , Adulto , Proteínas de Transporte , Doença Crônica , Feminino , Humanos , Masculino , Pancreatite Alcoólica/genética , Poli T/genética , Polimorfismo Genético , Inibidor da Tripsina Pancreática de Kazal
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...